Ken Griffin Rezolute, Inc. Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Rezolute, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 1,600 shares of RZLT stock, worth $8,159. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,600

Previous 1,000 60.0%

Holding current value

$8,159

Previous $4,000 75.0%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$4.13 - $5.31 $159,905 - $205,592	38,718 Added 11.47%	376,252 $1.82 Million
Q2 2024 Aug 14, 2024	SELL	$2.29 - $5.79 $139,435 - $352,547	-60,889 Reduced 15.28%	337,534 $1.45 Million
Q1 2024 May 15, 2024	BUY	$0.95 - $2.55 $49,280 - $132,278	51,874 Added 14.97%	398,423 $1.02 Million
Q4 2023 Feb 14, 2024	BUY	$0.74 - $1.24 $22,410 - $37,553	30,285 Added 9.58%	346,549 $343,000
Q3 2023 Nov 14, 2023	SELL	$1.32 - $2.1 $15,277 - $24,305	-11,574 Reduced 3.53%	316,264 $417,000
Q2 2023 Aug 14, 2023	SELL	$1.75 - $2.33 $22,748 - $30,287	-12,999 Reduced 3.81%	327,838 $649,000
Q1 2023 May 15, 2023	SELL	$1.79 - $2.87 $22,729 - $36,443	-12,698 Reduced 3.59%	340,837 $654,000
Q4 2022 Feb 14, 2023	BUY	$1.38 - $2.84 $56,793 - $116,880	41,155 Added 13.17%	353,535 $731,000
Q3 2022 Nov 14, 2022	BUY	$2.19 - $3.49 $9,749 - $15,537	4,452 Added 1.45%	312,380 $856,000
Q2 2022 Aug 15, 2022	SELL	$2.6 - $3.85 $52,065 - $77,096	-20,025 Reduced 6.11%	307,928 $995,000
Q1 2022 May 16, 2022	BUY	$2.27 - $5.1 $44,641 - $100,296	19,666 Added 6.38%	327,953 $1.11 Million
Q4 2021 Feb 14, 2022	SELL	$4.21 - $7.61 $7,152 - $12,929	-1,699 Reduced 0.55%	308,287 $0
Q3 2021 Nov 15, 2021	BUY	$7.45 - $13.66 $14,885 - $27,292	1,998 Added 0.65%	309,986 $2.3 Million
Q2 2021 Aug 16, 2021	SELL	$6.11 - $15.99 $26,566 - $69,524	-4,348 Reduced 1.39%	307,988 $0
Q1 2021 May 17, 2021	BUY	$6.83 - $17.3 $55,357 - $140,216	8,105 Added 2.66%	312,336 $2.21 Million
Q4 2020 Feb 16, 2021	BUY	$11.99 - $24.05 $3.65 Million - $7.32 Million	304,231 New	304,231 $3.76 Million

Others Institutions Holding RZLT

# of Institutions

Shares Held

38.5M

Call Options Held

1.6K

Put Options Held

24.6K

View Full List

About Rezolute, Inc.

Ticker RZLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,600
Market Cap $198M
Description
Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...

More about RZLT

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account